Skip to main content

e-Health

11
Mar 2025

Seven more health apps obtained reimbursement in Germany since February 2024

Between late February 2024 and early March 2025, seven more health apps were introduced in the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM) and thus became reimbursable. These apps can be prescribed by physicians and psychotherapists and will be reimbursed by health insurers. In total, 59 health apps are currently available in the DiGA Directory, and ten health apps were delisted from the Directory.
28
Feb 2025

Innovations awarded SBRI Healthcare competitions in February 2025 in England

In February 2025, SBRI Healthcare, funded by the NHS Accelerated Access Collaborative, announced the results of three competitions. Funding of £1.3m was allocated for the development of 14 innovations that support women’s health, £1m for the development of 11 innovations that improve infection prevention and control to mitigate the spread of antimicrobial resistance, and £3 million to support four innovations that improve the health and well-being of children and young people who have asthma, epilepsy, or diabetes.
26
Feb 2025

National evaluations commissioned to Swedish TLV in February 2025

In February 2025, the MTP Council announced national evaluations of two technologies within the Orderly introduction framework in Sweden. The Council commissioned the Dental and Pharmaceutical Benefits Agency (TLV) to perform a health economic evaluation of rectal spacers (SpaceOAR Hydrogel and Barrigel) used during radiotherapy in prostate cancer (re-evaluation) and AI-based solution (Stratipath Breast) for breast cancer risk assessment.
25
Feb 2025

French National Authority for Health published its 2025-2030 strategy

On February 4, 2025, the French National Authority for Health (HAS) published its 2025-2030 strategic project. The document outlines current challenges and opportunities in the health system, defines three strategic priorities, and identifies three key areas in which HAS intends to increase its investment over the next five years.
20
Feb 2025

Health apps reimbursed in Belgium since February 2025

In February 2025, seven health apps reached Level 3+ of the mHealthBelgium validation pyramid, meaning regular reimbursement. These apps can only be reimbursed within the specific care pathway “Remote monitoring and therapeutic guidance in chronic heart failure”.
11
Feb 2025

Med Tech-related technology assessments from NICE in January 2025

In January 2025, the National Institute for Health and Care Excellence (NICE) published two new Interventional Procedures Guidance (Transperineal laser ablation for lower urinary tract symptoms of benign prostatic hyperplasia, electrically stimulated intravesical therapy for interstitial cystitis or overactive bladder) and one new Early Value Assessment (Artificial intelligence technologies to help detect fractures on X-rays in urgent care). Furthermore, one new clinical guideline was published, and one was updated.
22
Jan 2025

Healthcare system changes in 2025 in Germany

The Federal Ministry of Health summarized multiple changes in the healthcare system that will be introduced in 2025. The most important ones relate to the further steps in digitalizing healthcare and hospital reform.
20
Jan 2025

First health apps are expected to enter reimbursement in Belgium by the end of January 2025

In December 2024, MTRC reported that the first health app had entered Level 3+ of the mHealthBelgium validation pyramid, indicating eligibility for regular reimbursement. However, no health apps are currently listed at Level 3 on the validation pyramid. mHealthBelgium clarified to MTRC that the December 2024 listing was part of a visual test to demonstrate how an app would appear at Level 3 on their website. They anticipate that the first apps will officially reach Level 3 by the end of January 2025.
17
Jan 2025

Med Tech-related technology assessments from NICE in December 2024

In December 2024, the National Institute for Health and Care Excellence (NICE) published three new Interventional Procedures Guidance (Direct skeletal fixation of limb prostheses using an intraosseous transcutaneous implant, MRI-guided focused ultrasound subthalamotomy and thalamotomy for treating Parkinson’s), one new Diagnostic Guidance (Home-testing devices for diagnosing OSAHS) and one new Early Value Assessment (Digital technologies to support self-management of COPD).